EMA: Update of the Annex to the Excipients Guideline
Recommendation
5/6 February 2025
Risk analysis, preventive measures and incident management
Register now for ECA's GMP Newsletter
In April 2024, the fourth revision of the Annex to the Guideline "Excipients in the labeling and package leaflet of medicinal products for human use" was published on the EMA website. The guideline, which has been available in the currently applicable version since March 2018, consists of the following chapters:
- INTRODUCTION
- PURPOSE
- DEFINITIONS AND EXAMPLES
- NOMENCLATURE
- EXCIPIENTS IN THE LABELLING
- EXCIPIENTS IN THE PACKAGE LEAFLET
- ANNEX: EXCIPIENTS AND INFORMATION FOR THE PACKAGE LEAFLET
Now the annex "EXCIPIENTS AND INFORMATION FOR THE PACKAGE LEAFLET" has been revised again and the information for polysorbates has been listed. The substances are listed in the annex in tabular and alphabetical order and the corresponding texts for the package leaflet are given. Furthermore, additional comments as well as the type of application and the corresponding threshold values are listed together with the update date.
The current version of the guideline "Excipients in the labeling and package leaflet of medicinal products for human use" and the "ANNEX: EXCIPIENTS AND INFORMATION FOR THE PACKAGE LEAFLET" can be found on the EMA website.
Related GMP News
17.12.2024IPEC: Updated GDP Guide for Excipients
27.11.2024Supplement 11.7 of the European Pharmacopoeia (Ph. Eur.) available
02.10.2024EC: New Requirements for 'PFAS' Subgroup adopted
24.09.2024US FDA Warning Letter: Testing of incoming Goods
24.09.2024EMA: Comments on Q&As for 'Co-processed Excipients' possible
18.09.2024FDA: Updated Guidance for Nitrosamines